irritable bowel syndrome
The CDPath prognostic tool gives Crohn's patients risk scores for serious complications within three years, so they can make more informed treatment decisions.
Genetic Analysis, Thalys Medical Technology Group to Develop Microbiome-Based LDTs in China
Thalys will use its Shanghai-based lab group to distribute tests based on Genetic Analysis' GA-map technology.
In particular, the diagnostics company expects the new resource to strengthen its offerings to pharmaceutical partners, a key customer group.
Theradiag to Commercialize PredictImmune IBD Test in French-Speaking Europe and Africa
Under the agreement, Theradiag will promote, license, and distribute PredictImmune's PredictSure IBD test in France, Belgium, Luxembourg, Switzerland, and the Maghreb countries.
FDA Clears Bühlmann Fecal Calprotectin Extraction Device
The device is intended for preparation of stool samples and use with Buhlmann's Fcal Turbo calprotectin test.
Sep 18, 2019
Progenity Acquires Medimetrics' Patent Portfolio
Sep 16, 2019
Cedars-Sinai Loses Suit Against Quest Over IBS Test
Jun 28, 2019
Bühlmann Labs IBD Assay FDA Cleared
Apr 25, 2019